Page 2 - P4403.14-V106 July Numark Pharmacy Mag 25
P. 2
Newly formulated
range of Ramipril
Oral Solution...
NOW IN
THREE
STRENGTHS
Patients with swallowing
difficulties may find a liquid
formulation easier to swallow
than tablets or capsules
*Switch from tablets and unlicensed medicines.
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and is utilised for multiple Scan the Scan the
indications, including hypertension and prevention of heart failure progression following QR code to access QR code to access
a myocardial infarction (MI). 1-3
the Rosemont Prescribing
References: 1. Ramipril 2.5mg/5ml Oral Solution SmPC. Rosemont Pharmaceuticals Ltd. website Information
2024. 2. Ramipril 5mg/5ml Oral Solution SmPC. Rosemont Pharmaceuticals Ltd. 2024.
3. Ramipril 10mg/5ml Oral Solution SmPC. Rosemont Pharmaceuticals Ltd. 2024.
Adverse events should be reported. Reporting forms and information
can be found at https://yellowcard.mhra.gov.uk. Adverse events
should also be reported to Rosemont at 0113 244 1400 or
pharmacovigilance@rosemontpharma.com
ROS000132-020 DOP: December 2024
10/06/2025 14:33:57
P4403.59-V66 Numark Mag July 2025 Final.indd 2 10/06/2025 14:33:57
P4403.59-V66 Numark Mag July 2025 Final.indd 2
03/01/2025 08:42
03725-01 Ramipril_Ad_A4_297x210_AW.indd 1
03725-01 Ramipril_Ad_A4_297x210_AW.indd 1 03/01/2025 08:42
